What is a multidisciplinary tumor board and should my Prostate Cancer case be presented

Understanding Multidisciplinary Tumor Boards for Prostate Cancer

What Is a Multidisciplinary Tumor Board?

A multidisciplinary tumor board (also called a molecular tumor board or virtual tumor board) is a collaborative meeting where multiple medical specialists review your cancer case together to develop a comprehensive treatment plan. Rather than seeing doctors one at a time, a tumor board brings together different experts in one discussion to share their perspectives on your specific situation.

Who Participates in a Tumor Board?

For prostate cancer, a typical tumor board might include:

• Medical oncologists (cancer drug specialists)
• Urologists (prostate/urinary system surgeons)
• Radiation oncologists (radiation therapy specialists)
• Pathologists (tissue/lab specialists who interpret biopsies)
• Radiologists (imaging specialists who read scans)
• Molecular biologists or bioinformaticians (specialists who interpret genetic/genomic testing)

According to the CancerPatientLab webinars, pathologist Tony Magliocco emphasizes that tumor boards work best when they're focused on treatment decisions, not just diagnosis. He explains: "I created the reports, not for other pathologists, but for oncologists... I'm saying, 'How do we kill that butterfly?' I don't care what kind of butterfly it is, we've got to kill it."

---

Should Your Prostate Cancer Case Be Presented?

Yes—especially if you have advanced or complex prostate cancer. Here's when a tumor board presentation is particularly valuable:

Strong Reasons to Request a Tumor Board Review:

✅ You have metastatic (spread) prostate cancer - particularly castrate-resistant prostate cancer (CRPC)

✅ Your cancer has progressed despite multiple treatments - you've tried several therapies and need fresh perspectives

✅ You have complex genomic/molecular testing results - your case involves biomarkers, mutations, or multi-omic analysis (transcriptomics, proteomics, spatial phenotyping)

✅ You're considering clinical trials - a tumor board can help match you to appropriate trials

✅ Your doctors disagree on treatment approach - multiple perspectives can help resolve conflicting recommendations

✅ You want personalized treatment planning - especially if standard guidelines don't clearly apply to your situation

Real-World Example from the Evidence:

Brian McCloskey, an advanced prostate cancer patient, exemplifies why tumor boards matter. His case involved:

• Comparing tumor tissue from his 2016 prostatectomy to a 2022 metastatic lesion
• Multi-omic analysis showing neuroendocrine transformation (his cancer was changing its characteristics)
• Standard pathology missing this critical finding
• A need to decide between continuing androgen deprivation therapy or switching to different treatment approaches

According to the webinar "Multi-omic Analysis Guides the Decisions of Brian McCloskey," Dr. [removed] McKay integrated his complex molecular data and recommended: cabozantinib (a VEGF inhibitor) combined with nivolumab (an immunotherapy)—a personalized approach that emerged from careful tumor board-style analysis.

---

How Tumor Boards Help With Treatment Decisions

STEP 1: INTEGRATE COMPLEX DATA

The board reviews all your information together:

• Pathology reports and tissue analysis
• Genomic testing (DNA sequencing, RNA sequencing)
• Imaging scans (CT, MRI, PET, PSMA scans)
• Lab values and PSA trends
• Your treatment history and response patterns

STEP 2: IDENTIFY TUMOR VULNERABILITIES

As Dr. [removed]Kay explains in the webinars: "Precision medicine can help identify a specific vulnerability that we can take advantage of with drugs that we otherwise would not be able to."

For example, the tumor board might identify:

• VEGF pathway dysregulation (suggesting VEGF inhibitors)
• BRCA mutations (suggesting PARP inhibitors)
• Neuroendocrine features (suggesting platinum chemotherapy or different approaches)
• Immune microenvironment characteristics (suggesting immunotherapy combinations)

STEP 3: CONSIDER MULTIPLE TREATMENT PATHWAYS

Rather than defaulting to standard approaches, the board considers:

• Targeted therapies based on your specific mutations
• Immunotherapy combinations
• Chemotherapy options
• Clinical trial eligibility
• Drug sequencing strategies
• Combination approaches

STEP 4: BALANCE QUALITY OF LIFE WITH DISEASE CONTROL

The board considers outcome goals like:

• Delaying disease progression
• Maintaining quality of life
• Managing side effects
• Preserving treatment options for the future

---

How to Request a Tumor Board Review

Questions to Ask Your Oncologist:

1. "Can my case be presented to a multidisciplinary tumor board?"

2. "What information would you need from me to present my case?" (pathology reports, imaging, genomic testing, treatment history)

3. "Who would be involved in reviewing my case?" (which specialists)

4. "How long does the process take, and when would I get recommendations?"

5. "Can I attend the tumor board discussion or get a summary of their recommendations?"

6. "Are there virtual tumor board options available?" (Some institutions offer telemedicine-based tumor boards)

What to Bring/Provide:

• All pathology reports and tissue slides
• Complete imaging studies (scans on CD or accessible electronically)
• Genomic/molecular testing results (DNA sequencing, RNA sequencing, biomarker panels)
• Treatment history (what drugs you've received and your response)
• Current lab values and PSA trends
• List of any clinical trials you're considering

---

Finding a Tumor Board

Options Include:

Academic Medical Centers - Major cancer centers like UCSD Health, Memorial Sloan Kettering, MD Anderson, and Dana-Farber have established tumor boards

Community Cancer Centers - Many regional cancer centers now offer tumor board reviews

Virtual/Remote Tumor Boards - Services like Protean (mentioned in the webinars) offer virtual tumor board platforms that can coordinate care across multiple institutions

Specialized Prostate Cancer Programs - Some centers have dedicated genitourinary (prostate/urinary) tumor boards

---

Important Considerations

⚠️ Choose Your "Quarterback" Carefully

The webinars emphasize: "Choose a quarterback for your care who is well-versed in the research and connected with you." This means:

• Your primary oncologist should be willing to integrate complex molecular testing data into treatment decisions
• They should be open to discussing multiple treatment pathways, not just standard approaches
• They should be willing to collaborate with other specialists and consider tumor board input

If your current oncologist is dismissive of advanced testing or unwilling to discuss personalized approaches, this may be a sign to seek a second opinion or find a more collaborative care team.

Quality Matters

Not all tumor boards are equally rigorous. Look for boards that:

• Include pathologists who review tissue carefully
• Have access to molecular/genomic specialists
• Consider clinical trial options
• Discuss treatment sequencing and combinations
• Focus on your specific case (not just generic guidelines)

---

Key Takeaway

A multidisciplinary tumor board is a powerful tool for advanced prostate cancer patients, especially those with complex cases, multiple treatment failures, or significant genomic findings. Rather than making treatment decisions in isolation, a tumor board brings together multiple expert perspectives to identify personalized vulnerabilities in your cancer and develop a comprehensive strategy.

According to the CancerPatientLab webinars, this collaborative approach has helped patients like Brian McCloskey move from feeling stuck to having 17+ potential treatment options—which his oncologist then refined down to the most promising approaches for his specific situation.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.